- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Getting Creative to Encourage Patient Engagement
Since the patient’s cost is effectively zero in the Medicaid population, getting patients engaged in their care often requires some ingenuity to figure out what the patient needs in order to be motivated in their own health, said Matt Salo.
“Is child care your biggest issue?” Salo asked. “Well let’s figure out: if you can go to the highest quality, lowest price provider, maybe we can kick in some child care subsidy or something like that. You can be creative.”
Figuring those things out is complicated, but can be done, and it aligns with the way insurance is changing to embrace social determinants of health, he added.
Leah Binder agreed that it is important to create incentives to creatively build benefits designs based on what the patients actually value. “But our healthcare system has no tradition at all of caring at all about what patients think,” she said.
And when the system does try to define quality, it’s usually in a scientific way that considers what is high quality or what the most people think. But the industry needs to start understanding the nuances between how different people view value, Binder said.
In the end, this will all come down to research, Austin Frakt, PhD, said. The data on these innovative models need to be available and accessible in order for independent researchers to know the effects of these programs.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
